Login to Your Account



FDA Stops Phase III Enrollment In Dendreon’s Provenge Trial

By Karen Young


Thursday, May 2, 2002
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription